Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer's disease. (Q39428145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

title

Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

Andrew J McKune

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

Jackson Thomas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

Duane Mellor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

Nenad Naumovski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

Demosthenes B. Panagiotakos

25 March 2020

3

object named as

Demosthenes B Panagiotakos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Ekavi N Georgousopoulou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

publication date

11 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

published in

Nutritional Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

1-18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

The role of inflammasome in Alzheimer's disease

25 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Neuropathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The genetic landscape of Alzheimer disease: clinical implications and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Forecasting the global burden of Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The worldwide costs of dementia 2015 and comparisons with 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Reversal of cognitive decline: a novel therapeutic program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Dietary patterns and risk of dementia: the Three-City cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Adherence to a Mediterranean diet, cognitive decline, and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Dietary patterns, cognitive decline, and dementia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

MIND diet slows cognitive decline with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Clinical value of nutritional status in neurodegenerative diseases: What is its impact and how it affects disease progression and management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Western diet is associated with a smaller hippocampus: a longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Reversal of cognitive decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Timing of Physical Activity, Apolipoprotein E ε4 Genotype, and Risk of Incident Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Modifiable risk factors for Alzheimer disease and subjective memory impairment across age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The Alzheimer's disease mitochondrial cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Immune attack: the role of inflammation in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Late-life social activity and cognitive decline in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Sleep, Cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Serum S-100beta as a possible marker of blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Neurotrophic protein S100 beta stimulates glial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Prediction of neuropsychological outcome after mild traumatic brain injury using clinical parameters, serum S100B protein and findings on computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S-100 B Concentrations Are a Predictor of Decreased Survival in Patients with Major Trauma, Independently of Head Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The addition of S100B to guidelines for management of mild head injury is potentially cost saving

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S100 as a marker of acute brain ischemia: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Use of S-100B, NSE, CRP and ESR to predict neurological outcomes in patients with return of spontaneous circulation and treated with hypothermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Cognitive function after major noncardiac surgery, apolipoprotein E4 genotype, and biomarkers of brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Acute sleep deprivation increases serum levels of neuron-specific enolase (NSE) and S100 calcium binding protein B (S-100B) in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Serum S100B as a Surrogate Biomarker in the Diagnoses of Burnout and Depression in Emergency Medicine Residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Human muscle satellite cells show age-related differential expression of S100B protein and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S100B's double life: intracellular regulator and extracellular signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Insulin Stimulates S100B Secretion and These Proteins Antagonistically Modulate Brain Glucose Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Evidence for a wide extra-astrocytic distribution of S100B in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Increased S100β in the cerebrospinal fluid of patients with frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S100B in neuropathologic states: the CRP of the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The dynamics of cortical and hippocampal atrophy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The Serum Concentration of the Calcium Binding Protein S100B is Positively Associated with Cognitive Performance in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Differential effects of interleukin-1beta and S100B on amyloid precursor protein in rat retinal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Learning and memory in S100-beta transgenic mice: an analysis of impaired and preserved function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Glial protein S100B modulates long-term neuronal synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Vitamin E increases S100B-mediated microglial activation in an S100B-overexpressing mouse model of pathological aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The blood-brain barrier in health and chronic neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Peripheral markers of blood-brain barrier damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Extracranial sources of S100B do not affect serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Blood-brain barrier breakdown in the aging human hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic Antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The APOE genotype: modification of therapeutic responses in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Relationship between ApoE gene polymorphism and coronary heart disease in Gaza Strip

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Plasma levels of apolipoprotein E and risk of dementia in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The release of S-100B and NSE in severe traumatic head injury is associated with APOE ε4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The effect of apolipoprotein E genotype on neuron specific enolase and S-100beta levels after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Saturated and trans fats and dementia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Diet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional Interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Preferential utilization of ketone bodies for the synthesis of myelin cholesterol in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Ketogenic diet in epileptic children: impact on lipoproteins and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Beta-hydroxy-butyrate alters the extracellular content of S100B in astrocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Ketogenic diet fed rats have low levels of S100B in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The ketogenic diet: metabolic influences on brain excitability and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Brain changes in BDNF and S100B induced by ketogenic diets in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Transitory gliosis in the CA3 hippocampal region in rats fed on a ketogenic diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

How does brain insulin resistance develop in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S100B impairs glycolysis via enhanced poly(ADP-ribosyl)ation of glyceraldehyde-3-phosphate dehydrogenase in rodent muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Brain fuel metabolism, aging, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S100B content and secretion decrease in astrocytes cultured in high-glucose medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Serum S100B protein is increased in fasting rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Decrease of serum S100B during an oral glucose tolerance test correlates inversely with the insulin response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Astrocytic and neuronal biochemical markers in the sera of subjects with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Food Inhibits the Oral Bioavailability of the Major Green Tea Antioxidant Epigallocatechin Gallate in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Effect of aqueous extract of Crocus sativus L. (saffron) stigma against subacute effect of diazinon on specific biomarkers in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Silymarin: a novel antioxidant with antiglycation and antiinflammatory properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The Effects of Resveratrol Supplementation in Overweight and Obese Humans: A Systematic Review of Randomized Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Escalated regeneration in sciatic nerve crush injury by the combined therapy of human amniotic fluid mesenchymal stem cells and fermented soybean extracts, Natto

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Cinnamon polyphenols attenuate the hydrogen peroxide-induced down regulation of S100β secretion by regulating sirtuin 1 in C6 rat glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Exercise interventions for cognitive function in adults older than 50: a systematic review with meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S100B as a marker for brain damage and blood-brain barrier disruption following exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Consequences of repeated blood-brain barrier disruption in football players

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Boxing and running lead to a rise in serum levels of S-100B protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S100B profiles and cognitive function at high altitude.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Serum levels of S100B are decreased in chronic starvation and normalize with weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

S100B in underweight and weight-recovered patients with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Ketogenic diet in neuromuscular and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Saturated Fats Compared With Unsaturated Fats and Sources of Carbohydrates in Relation to Risk of Coronary Heart Disease: A Prospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Novel ketone diet enhances physical and cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Effects of beta-hydroxybutyrate on cognition in memory-impaired adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Dietary patterns and cognitive decline in an Australian study of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Association of Seafood Consumption, Brain Mercury Level, and APOE ε4 Status With Brain Neuropathology in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

High-Fat Diet Changes Hippocampal Apolipoprotein E (ApoE) in a Genotype- and Carbohydrate-Dependent Manner in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Apolipoprotein E (APOE) genotype regulates body weight and fatty acid utilization-Studies in gene-targeted replacement mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Caloric intake and the risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Glucose levels and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1028415X.2017.1349032

10.1080/1028415X.2017.1349032

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28696163 AND SRC:MED&resulttype=core&format=json

release_ijyv4cj47vcenppklsooazb6mi

25 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ijyv4cj47vcenppklsooazb6mi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference